Navigation Links
New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development

investment in research, development and its application. We need to give innovators and investors tangible encouragement to take the kinds of risks that are necessary to have big medical breakthroughs. Outdated policies in this area must be improved."

Gephardt also emphasized how science education, and the research and discovery that comes out of it, needs to be the backbone of the nation's overall economic strategy. "As a country we need to encourage more students to participate in science, technology, engineering and mathematics (STEM) education, attract the best and brightest researchers to our universities, and support basic scientific research and development."

Panelists participating in today's forum included top minds in academia, industry, and patient advocacy:

  • Bob Franks, President of the HealthCare Institute of New Jersey
  • Kathy Ahearn O'Brien, Executive Director of the Hyacinth AIDS Foundation
  • Linda Brown, Director of Business Development at PAREXEL International
  • John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics
  • David Knowlton, President and CEO of the New Jersey Health Care Quality Institute
  • Donald H. Sebastian, Ph.D., Senior Vice President for Research and Development and Interim Provost of the New Jersey Institute of Technology
  • Wise Young, M.D., Ph.D., Professor II of Cell Biology & Neuroscience at Rutgers University, and Director of the W. M. Keck Center for Collaborative Neuroscience/The Spinal Cord Injury Project at Nelson Labs

The Council for American Medical Innovation is a national coalition of leaders in research, medicine, public health, academia, education, labor, and business, who have joined together to urge policymakers to adopt a national policy agenda aimed at preserving U.S. leadership in medical innovation. The Council for Ameri

SOURCE Council for American Medical Innovation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for Best and Brightest Forum on Medical Innovation
2. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
3. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
4. Glycominds Appoints Board of Directors Chairman
5. Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
6. Allied Minds Launches Novel Disinfectant/Disinfestant Technology Start-up With UC Davis
7. Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities.
8. Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss
9. Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
10. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
11. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
Post Your Comments:
(Date:9/30/2014)... 2014 BioHealth Innovation, Inc. (BHI), ... innovations and increasing access to early-stage funding in ... capitalist, Tania Fernandez , Ph.D., has joined the ... be a member of the management team for a ... $50 million in seed and early-stage equity investments to ...
(Date:9/30/2014)... September 30, 2014 The custom stainless ... Boston Product Show 2014. The Boston Area Chapter of ... 23rd annual, day-long event for Wed., Oct. 1 at ... to be the largest in ISPE Boston’s long history, ... of 3,000 attendees expected. , HOLLOWAY AMERICA President ...
(Date:9/30/2014)... On September 11, Pharma IQ conducted an ... of a session that he will lead on “Stem Cells” ... February 17-18, 2015 in London. In the interview posted ... Sherley to respond to several questions on the current state ... stem cell toxicity, and future trends in the use of ...
(Date:9/30/2014)... Pittsburgh PA (PRWEB) September 30, 2014 ... Nurses ( IACRN), a non-profit organization based ... Clinical Research Excellence and Safety (ACRES), a ... of a strategic alliance agreement, setting the stage ... is to enhance clinical research quality and safety ...
Breaking Biology Technology:Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4IACRN and ACRES to Support Clinical Research Nurses 2IACRN and ACRES to Support Clinical Research Nurses 3
... InNexus,Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX ... commercializing the next,generation of monoclonal antibodies based on ... Morhet, CEO and Chairman, will,present at the 7th ... Mr. Morhet,s thirty-minute presentation to potential investors ...
... NOVATO, Calif., Oct. 28 , Financial Highlights ($ in millions, except per share data), Item ... Q3 2007 Comparison Total BioMarin Revenue $72.6 ... Product Revenue $33.3 ... $38.2 ...
... DiaGenic ASA (OSL:DIAG),today announced that it has ... leading panEuropean provider of gene expression-based,diagnostic testing ... following,CE marking scheduled in early2009, DiaGenic will ... in Europe its innovative blood-based,gene-expression diagnostic test ...
Cached Biology Technology:InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum 2BioMarin Announces Third Quarter 2008 Financial Results 2BioMarin Announces Third Quarter 2008 Financial Results 3BioMarin Announces Third Quarter 2008 Financial Results 4BioMarin Announces Third Quarter 2008 Financial Results 5BioMarin Announces Third Quarter 2008 Financial Results 6BioMarin Announces Third Quarter 2008 Financial Results 7BioMarin Announces Third Quarter 2008 Financial Results 8BioMarin Announces Third Quarter 2008 Financial Results 9BioMarin Announces Third Quarter 2008 Financial Results 10BioMarin Announces Third Quarter 2008 Financial Results 11BioMarin Announces Third Quarter 2008 Financial Results 12Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests 2
(Date:9/30/2014)... Ecker, a Salk professor and Howard Hughes Medical ... have been named recipients in the 2014 round ... (NIH) through the BRAIN (Brain Research through Advancing ... The grant, announced September 30, provides more than ... over three years. , The BRAIN Initiative, launched ...
(Date:9/30/2014)... available in German . ... most expensive foods in the world. Because they grow underground, ... the distinctive smell of truffles is not only of interest ... the direction of the Goethe University Frankfurt have discovered that ... bacteria which are trapped inside truffle fruiting bodies. , White ...
(Date:9/30/2014)... pregnanteven with IVF? Here,s some hope: A new research ... The FASEB Journal , explains how scientists developed ... PAWP, which induced embryo development in human and mouse ... by the sperm cell during fertilization. , "We believe ... paradigm shift in our understanding of human fertilization by ...
Breaking Biology News(10 mins):Salk scientists receive $3 million for BRAIN Initiative grant 2On the trail of the truffle flavor 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... Sanford-Burnham Medical Research Institute, a nonprofit research institution ... the world, and Intrexon Corporation, a leading synthetic ... accelerate stem cell research. Under the agreement, Sanford-Burnham ... and gene regulation technologies that are not currently ...
... This press release is available in Spanish ... scientists are developing strategies to help livestock producers control ... in the United States. An economic ... (ARS) Agroecosystem Management Research Unit (AMRU) in Lincoln, Neb., ...
... drugs are taken off the market and a major reason ... reporting the development of a new way to predict those ... which could save patients from severe side effects and save ... of Chemical Information and Modeling . Yoshihiro Yamanishi and ...
Cached Biology News:Sanford-Burnham and Intrexon Corporation establish collaboration to accelerate stem cell research 2Sanford-Burnham and Intrexon Corporation establish collaboration to accelerate stem cell research 3Treating stable flies in pastures 2
Taq DNA polymerase, 10,000U...
... is the most thoroughly characterized enzyme available ... its overall utility and efficacy. , Its ... PCR applications. , It is QC ... AmpliTaq DNA Polymerase is a 94 kDa ...
Taq DNA Polymerase (T. aquaticus), 4 x 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying En...
... GCpro Taq DNA Polymerase is a versatile ... for all PCR applications. GCpro Taq DNA ... expressed in E. coli, containing the DNA ... enzyme includes a highly processive 5'-3' DNA ...
Biology Products: